Published in BMJ on February 08, 2007
3 Months' Versus 6 Months' Anticoagulation in Patients With DVT and/or PE | NCT00365950
Deep vein thromboses in users of opioid drugs: incidence, prevalence, and risk factors. Br J Gen Pract (2011) 1.13
Acute pulmonary embolism. Part 2: treatment. Nat Rev Cardiol (2010) 0.96
Predicting the risk of venous thromboembolism recurrence. Am J Hematol (2012) 0.88
Clinical evidence for rebound hypercoagulability after discontinuing oral anticoagulants for venous thromboembolism. Medscape J Med (2008) 0.86
Evaluating patient values and preferences for thromboprophylaxis decision making during pregnancy: a study protocol. BMC Pregnancy Childbirth (2012) 0.82
Large blood vessel stretch in lumbar spine through anterior surgical approach: An experimental study in adult goat. Indian J Orthop (2014) 0.80
Thromboembolism. BMJ Clin Evid (2011) 0.79
Bilateral pulmonary emboli in a collegiate gymnast: a case report. J Athl Train (2009) 0.78
Venous thromboembolism: Predicting recurrence and the need for extended anticoagulation. Vasc Med (2015) 0.77
Measures of vitamin K antagonist control reported in atrial fibrillation and venous thromboembolism studies: a systematic review. BMJ Open (2014) 0.76
Anticoagulation for venous thromboembolism. BMJ (2007) 0.76
Contrast enhanced pulmonary magnetic resonance angiography for pulmonary embolism: Building a successful program. Eur J Radiol (2015) 0.75
Diagnosis and Treatment of Lower Extremity Deep Vein Thrombosis: Korean Practice Guidelines. Vasc Specialist Int (2016) 0.75
6 or 3 months of anticoagulant therapy did not differ for treatment failure in patients with DVT, PE, or both. ACP J Club (2007) 0.75
6 or 3 months of anticoagulant therapy did not differ for treatment failure in patients with DVT, PE, or both. Evid Based Med (2007) 0.75
A re-appraisal of warfarin control in the treatment of deep vein thrombosis and / or pulmonary embolism. Afr Health Sci (2009) 0.75
Is 3 months the optimum duration of anticoagulation therapy for deep vein thrombosis and pulmonary embolism? Nat Clin Pract Cardiovasc Med (2007) 0.75
Different Finite Durations of Anticoagulation and Outcomes following Idiopathic Venous Thromboembolism: A Meta-Analysis. Thrombosis (2010) 0.75
Factor V leiden thrombophilia in a female collegiate soccer athlete: a case report. J Athl Train (2013) 0.75
Anticoagulant drugs in the treatment of pulmonary embolism. A controlled trial. Lancet (1960) 7.96
ICH Harmonised Tripartite Guideline. Statistical principles for clinical trials. International Conference on Harmonisation E9 Expert Working Group. Stat Med (1999) 7.32
The long-term clinical course of acute deep venous thrombosis. Ann Intern Med (1996) 6.87
D-dimer testing to determine the duration of anticoagulation therapy. N Engl J Med (2006) 6.62
Antithrombotic therapy for venous thromboembolic disease: the Seventh ACCP Conference on Antithrombotic and Thrombolytic Therapy. Chest (2004) 5.96
British Thoracic Society guidelines for the management of suspected acute pulmonary embolism. Thorax (2003) 5.83
A comparison of three months of anticoagulation with extended anticoagulation for a first episode of idiopathic venous thromboembolism. N Engl J Med (1999) 5.14
A comparison of six weeks with six months of oral anticoagulant therapy after a first episode of venous thromboembolism. Duration of Anticoagulation Trial Study Group. N Engl J Med (1995) 4.71
Optimum duration of anticoagulation for deep-vein thrombosis and pulmonary embolism. Research Committee of the British Thoracic Society. Lancet (1992) 3.60
Suspected acute pulmonary embolism: a practical approach. British Thoracic Society, Standards of Care Committee. Thorax (1997) 3.59
PULMONARY EMBOLISM. Br Med J (1963) 3.33
Duration of anticoagulation following venous thromboembolism: a meta-analysis. JAMA (2005) 3.27
Three months versus one year of oral anticoagulant therapy for idiopathic deep venous thrombosis. Warfarin Optimal Duration Italian Trial Investigators. N Engl J Med (2001) 3.07
Guidelines on oral anticoagulation (warfarin): third edition--2005 update. Br J Haematol (2006) 3.03
Heparin for 5 days as compared with 10 days in the initial treatment of proximal venous thrombosis. N Engl J Med (1990) 2.63
Post-thrombotic syndrome, recurrence, and death 10 years after the first episode of venous thromboembolism treated with warfarin for 6 weeks or 6 months. J Thromb Haemost (2006) 2.32
Extended oral anticoagulant therapy after a first episode of pulmonary embolism. Ann Intern Med (2003) 2.28
Recurrent venous thromboembolism after deep vein thrombosis: incidence and risk factors. Arch Intern Med (2000) 1.81
Anticoagulants in venous thromboembolism. BMJ (1988) 1.77
Safety and efficacy of warfarin started early after submassive venous thrombosis or pulmonary embolism. Lancet (1986) 1.58
Intensive initial oral anticoagulation and shorter heparin treatment in deep vein thrombosis. Thromb Haemost (1984) 1.24
One-month versus six-month therapy with oral anticoagulants after symptomatic deep vein thrombosis. Acta Med Scand (1985) 1.17
Assessment of anticoagulant treatment of venous thromboembolism. Ann Surg (1969) 1.06
A comparison of 3 and 6 weeks' anticoagulation in the treatment of venous thromboembolism. Clin Lab Haematol (1987) 1.00
Duration of anticoagulant therapy in venous thrombo--embolism. Med J Aust (1972) 0.97
The effect of the duration of anticoagulation and other risk factors on the recurrence of venous thromboembolisms. Duration of Anticoagulation Study Group. Wien Med Wochenschr (1999) 0.96
The optimal duration of anticoagulant therapy for venous thrombosis. N Engl J Med (1995) 0.94
Management of venous thromboembolism. Lancet (1988) 0.90
Risk of major bleeding in unselected patients with venous thromboembolism. Blood Coagul Fibrinolysis (2000) 0.86
14 years of follow-up from the Edinburgh randomised trial of breast-cancer screening. Lancet (1999) 4.80
Edinburgh Artery Study: prevalence of asymptomatic and symptomatic peripheral arterial disease in the general population. Int J Epidemiol (1991) 4.67
Day care after operations for hernia or varicose veins: a controlled trial. Br J Surg (1978) 4.30
Prospective study of heart rate variability and mortality in chronic heart failure: results of the United Kingdom heart failure evaluation and assessment of risk trial (UK-heart). Circulation (1998) 3.99
Familial Hypercholesterolaemia Regression Study: a randomised trial of low-density-lipoprotein apheresis. Lancet (1995) 3.74
Twelve-year comparison of a Bjork-Shiley mechanical heart valve with porcine bioprostheses. N Engl J Med (1991) 3.31
Management of acute stroke in the elderly: preliminary results of a controlled trial. Br Med J (1980) 3.15
Patient reporting of suspected adverse drug reactions: a review of published literature and international experience. Br J Clin Pharmacol (2007) 2.97
Randomised controlled trial of conservation therapy for breast cancer: 6-year analysis of the Scottish trial. Scottish Cancer Trials Breast Group. Lancet (1996) 2.78
Comprehensive clinical drug information service: first year's experience. Br Med J (1977) 2.77
Uptake and acceptability of antenatal HIV testing: randomised controlled trial of different methods of offering the test. BMJ (1998) 2.73
Management of acute stroke in the elderly: follow-up of a controlled trial. Br Med J (1980) 2.67
British Thoracic Society Sarcoidosis study: effects of long term corticosteroid treatment. Thorax (1996) 2.58
The prevalence of diabetic impotence. Diabetologia (1980) 2.47
Cutaneous vasculitis in patients with myelodysplasia. Br J Haematol (1990) 2.33
Elective versus symptomatic antibiotic treatment in cystic fibrosis patients with chronic Pseudomonas infection of the lungs. Thorax (2000) 2.31
Management of the axilla in operable breast cancer treated by breast conservation: a randomized clinical trial. Edinburgh Breast Unit. Br J Surg (2000) 2.30
Serum ferritin concentration as an index of storage iron in rheumatoid arthritis. J Clin Pathol (1974) 2.30
A numerical prognostic index for clinical use in identification of poor-risk patients with Hodgkin's disease at diagnosis. The Scotland and Newcastle Lymphoma Group (SNLG) Therapy Working Party. Leuk Lymphoma (1992) 2.23
A comparison of dermatologists', surgeons' and general practitioners' surgical management of cutaneous melanoma. Br J Dermatol (2004) 2.14
Changing patterns of self-poisoning in a UK health district. QJM (1996) 2.13
Human T-lymphotropic virus type III (HTLV-III) infection in seronegative haemophiliacs after transfusion of factor VIII. Lancet (1985) 2.08
Clinical and ultrasound prediction of macrosomia in diabetic pregnancy. Br J Obstet Gynaecol (1996) 2.05
Factors affecting warfarin requirements. A prospective population study. Eur J Clin Pharmacol (1979) 1.95
Consumer acceptability of day care after operations for hernia or varicose veins. J Epidemiol Community Health (1978) 1.90
Inter-relations between relapses, drug regimens and compliance with treatment in tuberculosis. Respir Med (1991) 1.85
Flexible induction dose regimen for warfarin and prediction of maintenance dose. Br Med J (Clin Res Ed) (1984) 1.83
Clinical pharmacokinetics of propranolol. Clin Pharmacokinet (1979) 1.81
Anticoagulants in venous thromboembolism. BMJ (1988) 1.77
The clinical course and management of thoracic empyema. QJM (1996) 1.76
Lidocaine plasma protein binding. Clin Pharmacol Ther (1980) 1.74
Healing of broken human chromosomes by the addition of telomeric repeats. Am J Hum Genet (1994) 1.69
The relationship between QT intervals and mortality in ambulant patients with chronic heart failure. The united kingdom heart failure evaluation and assessment of risk trial (UK-HEART) Eur Heart J (1999) 1.68
Bile acids in the diarrhoea of ileal resection. Gut (1973) 1.68
Adenosine stimulates respiration in man. Br J Clin Pharmacol (1985) 1.67
Comparison of maximal acid output and gastrin response to meals in Chinese and Scottish normal and duodenal ulcer subjects. Gut (1980) 1.67
Evaluation of an automatic platelet counting system utilizing whole blood. J Clin Pathol (1972) 1.66
Predicting functional outcome following acute stroke using a standard clinical examination. Stroke (1982) 1.65
The Edinburgh randomised trial of breast cancer screening: results after 10 years of follow-up. Br J Cancer (1994) 1.65
Safety of late acetylcysteine treatment in paracetamol poisoning. Hum Exp Toxicol (1990) 1.65
Randomised comparison of 5 years of adjuvant tamoxifen with continuous therapy for operable breast cancer. The Scottish Cancer Trials Breast Group. Br J Cancer (1996) 1.64
Random and systematic medication errors in routine clinical practice: a multicentre study of infusions, using acetylcysteine as an example. Br J Clin Pharmacol (2001) 1.63
Does obesity compromise survival in women with breast cancer? Breast (2004) 1.63
Predicting patients' warfarin requirements. Lancet (1977) 1.61
Histology in breast cancer prognosis. Br J Cancer (1972) 1.58
Arthropathy, ankylosing spondylitis, and clubbing of fingers in ulcerative colitis. Gut (1970) 1.57
Phosphate enemas in childhood: cause for concern. BMJ (1991) 1.55
Progressive coronary calcification despite intensive lipid-lowering treatment: a randomised controlled trial. Heart (2006) 1.55
A randomized trial comparing heater probe plus thrombin with heater probe plus placebo for bleeding peptic ulcer. Gastroenterology (2003) 1.54
Predictable and unpredictable hazards of erythropoietic protoporphyria. Clin Exp Dermatol (1991) 1.49
The plasma protein binding of basic drugs. Br J Clin Pharmacol (1986) 1.49
Research: the community nurse and day surgery. Nurs Times (1980) 1.49
A study of eleven cutaneous malignant melanomas in adults with small-cell morphology: emphasis on diagnostic difficulties and unusual features. Histopathology (2002) 1.44
The cytological detection of persistent cervical intraepithelial neoplasia after local ablative treatment: a comparison of sampling devices. Br J Obstet Gynaecol (1992) 1.44
Randomised, double blind placebo controlled trial of pentoxifylline in the treatment of venous leg ulcers. BMJ (1999) 1.44
A population-based, controlled study of the relation between HIV infection and cervical neoplasia. Br J Obstet Gynaecol (1994) 1.44
Scottish adjuvant tamoxifen trial: a randomized study updated to 15 years. J Natl Cancer Inst (2001) 1.44
Atropine as possible contaminant of comfrey tea. Lancet (1989) 1.43
Smoking, lipids, glucose intolerance, and blood pressure as risk factors for peripheral atherosclerosis compared with ischemic heart disease in the Edinburgh Artery Study. Am J Epidemiol (1992) 1.43
Rett syndrome: analysis of deaths in the British survey. Eur Child Adolesc Psychiatry (1997) 1.43
Transdermal nicotine plus support in patients attending hospital with smoking-related diseases: a placebo-controlled study. Respir Med (1996) 1.43
Dynamics of reactive oxygen intermediate production in human glioma: n-6 essential fatty acid effects. Eur J Clin Invest (1999) 1.42
Variability of ankle and brachial systolic pressures in the measurement of atherosclerotic peripheral arterial disease. J Epidemiol Community Health (1988) 1.41
The treatment of resistant warts with intralesional bleomycin: a controlled clinical trial. Br J Dermatol (1984) 1.41
Digoxin and mortality in chronic heart failure. UK Heart Investigation. Lancet (1999) 1.40
Community exposures to chemical incidents: development and evaluation of the first environmental public health surveillance system in europe. J Epidemiol Community Health (2000) 1.39
Twenty year comparison of a Bjork-Shiley mechanical heart valve with porcine bioprostheses. Heart (2003) 1.39
Functional assessment of patients undergoing day-care surgery for varicose veins or hernia: results from a randomised controlled trial. Health Bull (Edinb) (1979) 1.39
Popliteal vein reflux reduces the healing of chronic venous ulcer. Br J Surg (1998) 1.39
Acetazolamide in prevention of acute mountain sickness: a double-blind controlled cross-over study. Br Med J (Clin Res Ed) (1981) 1.39
General practitioners' response to day care surgery. Practitioner (1978) 1.39
The effect of intravenous aminophylline on essential tremor. Br J Clin Pharmacol (1997) 1.38
Autologous transfusion--too far, too soon? Vox Sang (1991) 1.38
A confidential inquiry into asthma deaths in Wales. Thorax (1999) 1.36
Nebulised salbutamol without oxygen in severe acute asthma: how effective and how safe? Thorax (1985) 1.36
Pharmacokinetics and pharmacodynamics of warfarin at steady state. Br J Clin Pharmacol (1979) 1.36
Increased alpha-1-acid glycoprotein and lidocaine disposition in myocardial infarction. Ann Intern Med (1980) 1.35
A clinical trial in the management of operable cancer of the breast. Br J Surg (1980) 1.35
Lignocaine disposition in blood in epilepsy. Br J Clin Pharmacol (1981) 1.35
Does right ventricular function predict survival in patients with chronic obstructive lung disease? Thorax (1988) 1.33
Controlled trial of sotalol for one year after myocardial infarction. Lancet (1982) 1.32
Sex-related differences in the plasma protein binding of lignocaine and diazepam. Br J Clin Pharmacol (1981) 1.32
Observer variation in the clinical assessment of stroke. Age Ageing (1976) 1.31
Transient bradycardia and subsequent sinus tachycardia produced by intravenous adenosine in healthy adult subjects. Br J Clin Pharmacol (1986) 1.29
Does vasectomy accelerate testicular tumour? Importance of testicular examinations before and after vasectomy. BMJ (1990) 1.28
High-performance liquid chromatographic analysis of isoniazid and acetylisoniazid in biological fluids. J Chromatogr (1983) 1.27
Glutathione reduces the toxicity and improves quality of life of women diagnosed with ovarian cancer treated with cisplatin: results of a double-blind, randomised trial. Ann Oncol (1997) 1.26
Free and total plasma theophylline concentrations in chronic airflow obstruction. Thorax (1984) 1.26
Accidental poisoning in children: can we admit fewer children with safety? Arch Dis Child (1991) 1.25
Iron metabolism and anaemia in pregnancy. Clin Haematol (1985) 1.24
Faecal stasis and diverticular disease in ulcerative colitis. Gut (1970) 1.23
Bcl-2/Bax ratios in chronic lymphocytic leukaemia and their correlation with in vitro apoptosis and clinical resistance. Br J Cancer (1997) 1.23
A simple method for determining acetylator phenotype using isoniazid. Br J Clin Pharmacol (1986) 1.22
The impact of nationally distributed guidelines on the management of paracetamol poisoning in accident and emergency departments. National Poison Information Service. J Accid Emerg Med (1998) 1.22